Free Trial

GT Biopharma (GTBP) Earnings Date, Estimates & Call Transcripts

GT Biopharma logo
$2.35 +0.06 (+2.40%)
As of 05/6/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

GT Biopharma Earnings Summary

Upcoming Q3
Earnings Date
May. 13Before Market OpensEstimated
Actual EPS
(Aug. 14)
-$2.24 Missed By -$2.24

GT Biopharma issued Q2 2024 earnings on August 14, 2024, reporting an EPS of -$2.24. With a trailing EPS of -$7.00, GT Biopharma's earnings are expected to grow next year, from ($6.79) to ($2.11) per share.

Q2 2024 Earnings Resources

GTBP Upcoming Earnings

GT Biopharma's Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled on Wednesday, May 14, 2025 at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get GT Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GT Biopharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GTBP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GT Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.64-$0.64-$0.64
Q2 20251-$0.59-$0.59-$0.59
Q3 20251-$0.55-$0.55-$0.55
Q4 20251-$0.52-$0.52-$0.52

GT Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025
(Estimated)
--------
8/14/2024Q2 2024--$2.24 -$2.24-$2.31--
5/15/2024Q1 2024-$2.70-$2.12+$0.58-$2.60--
11/1/2023Q3 2023-$3.00-$1.80+$1.20-$0.06--
8/7/2023Q2 2023-$3.00-$2.70+$0.30-$0.13--
5/15/2023Q1 2023-$4.80-$2.40+$2.40-$0.15--

GT Biopharma Earnings - Frequently Asked Questions

GT Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on GTBP's earnings history.

GT Biopharma (NASDAQ:GTBP) has a recorded net income of -$7.60 million. GTBP has generated -$7.00 earnings per share over the last four quarters.

GT Biopharma's earnings are expected to grow from ($6.79) per share to ($2.11) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:GTBP) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners